(±)-Naproxen-13C,d3
Modify Date: 2024-01-28 14:37:23
(±)-Naproxen-13C,d3 structure
|
Common Name | (±)-Naproxen-13C,d3 | ||
|---|---|---|---|---|
| CAS Number | 1261392-52-2 | Molecular Weight | 234.270 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C1313CH11D3O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of (±)-Naproxen-13C,d3(±)-Naproxen-13C,d3 is the deuterium and 13C labeled (±)-Naproxen[1]. (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively. |
| Name | 2-{6-[(13C,2H3)Methyloxy]-2-naphthyl}propanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | (±)-Naproxen-13C,d3 is the deuterium and 13C labeled (±)-Naproxen[1]. (±)-Naproxen ((Rac)-Naproxen) is a racemate of Naproxen (HY-15030). Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C1313CH11D3O3 |
| Molecular Weight | 234.270 |
| Exact Mass | 234.116486 |
| Index of Refraction | 1.609 |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301 |
| Precautionary Statements | P301 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |
| 2-Naphthaleneacetic acid, α-methyl-6-(methyl-13C-d3-oxy)- |
| 2-{6-[(13C,2H3)Methyloxy]-2-naphthyl}propanoic acid |